Second malignancies after treatment for Ewing's sarcoma: A report of the CESS-studies

International Journal of Radiation Oncology Biology Physics

Volumn 42, Issue 2, 1998, Pages 379-384

  Dunst, Jürgen ^a   Ahrens, Susanne ^c   Paulussen, Michael ^c   Rübe, Christian ^c   Winkelmann, Wilfried ^c   Zoubek, Andreas ^b   Harms, Dieter ^c   Jürgens, Herbert ^c  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b ST ANNA CHILDREN S HOSPITAL   (Austria)

^c Department of Radiotherapy ^*

Author keywords

Chemotherapy; Childhood cancer; Ewing's sarcoma; Leukemia; Radiotherapy; Second neoplasms

Indexed keywords

CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; IFOSFAMIDE; VINCRISTINE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CHILDHOOD CANCER; EWING SARCOMA; HUMAN; LEUKEMIA; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; RADIATION DOSE; SECOND CANCER; SOLID TUMOR;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; HUMANS; IFOSFAMIDE; LEUKEMIA, MYELOCYTIC, ACUTE; MYELODYSPLASTIC SYNDROMES; NEOPLASMS, SECOND PRIMARY; RADIOTHERAPY DOSAGE; SARCOMA; SARCOMA, EWING'S; TIME FACTORS; VINCRISTINE;

EID: 0032170181     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00228-4     Document Type: Article

References (14)

1. Hawkins M.M. Second primary tumors following radiotherapy for childhood cancer. Int J Radiat Oncol Biol Phys. 19:1990;1297-1301.
2. Hawkins M.M., Wilson L.M., Burton H.S., et al. Radiotherapy, alkylating agents, and the risk of bone cancer after childhood cancer. J Natl Cancer Inst. 88:1996;270-278.
3. Meadows A.T., Baum E., Fossati-Bellani F., et al. Second malignant neoplasms in children An update from The Late Effects Study Group . J Clin Oncol. 3:1985;532-538.
4. Tucker M.A., D'Angio G.J., Boice J., et al. Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med. 317:1987;588-593.
5. Heyn R., Haeberlen V., Newton W.A. Second malignant neoplasms in children treated for rhabdomyosarcoma. J Clin Oncol. 11:1993;262-270.
6. Olson J.H., Garwicz S., Hertz H. Second malignant neoplasms after cancer in childhood or adolescence. Br Med J. 307:1993;1030-1036.
7. Potish R.A., Dehner L.P., Haselow R.E. The incidence of second neoplasms following megavoltage radiation for pediatric tumors. Cancer. 56:1985;1534-1537.
8. Dunst J., Sauer R., Burgers J.M.V., et al. Radiotherapy as local treatment in Ewing's sarcoma Results of the cooperative Ewing's sarcoma studies CESS 81 and CESS 86 . Cancer. 67:1991;2818-2835.
9. Dunst J., Jürgens H., Sauer R., et al. Radiotherapy for Ewing's sarcoma of bone An update of the CESS86-data . Int J Radiat Oncol Biol Phys. 32:1995;919-930.
10. Kuttesch J.F., Wexler L.H., Marcus R.B., et al. Second malignancies after Ewing's sarcoma Radiation dose-dependency of secondary sarcomas . J Clin Oncol. 14:1996;2818-2825.
11. Newton W.A., Meadows A.T., Shimada H., et al. Bone sarcomas as second malignant neoplasms following childhood cancer. Cancer. 67:1991;193-201.
12. Smith L.M., Cox R.S., Donaldson S.S. Second cancers in long-term survivors of Ewing's sarcoma. Clin Orthop. 274:1992;275-281.
13. Strong L.C., Herson J., Osborne B.M. Risk of radiation-related subsequent malignant tumors in survivors of Ewing's sarcoma. J Natl Cancer Inst. 62:1979;1401-1406.
14. Dunst J., Jürgens H., Hoffmann C., et al. Surgery or radiotherapy in good-risk Ewing's sarcoma? Strahlenther Onkol. 172:1996;244-248.